Coagulation tests help in measuring the clotting ability of blood. Clotting is the process of blood converting from liquid into gel form. Coagulation tests are performed to analyze clotting disorders such as hemorrhage and thrombosis. Coagulation tests include complete blood count, factor V assay, fibrinogen level, prothrombin time, platelet count, thrombin time, and bleeding time. Coagulation testing analyzers play a major role in improving patients' quality of life.
TechNavio's analysts forecast the Global Coagulation Testing market to grow at a CAGR of 5.62 percent over the period 2013-2018.
Covered in this Report
The Global Coagulation Testing market can be segmented into the revenue generated from end- user application such as: Point-of-Care Coagulation Testing and Home Diagnostics.
TechNavio's report, the Global Coagulation Testing market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Coagulation Testing market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• EMEA
• APAC
Key Vendors
• Abbott Laboratories
• Danaher
• F. Hoffmann-La Roche
• Sysmex
Other Prominent Vendors
• Alere
• Cepheid
• CoaguSense
• HYPEN BioMed
• Helena Laboratories
• LABiTec
• Medtronic
• Siemens
• Sienco
• Stago
Market Driver
• Increase in Prevalence of CVD
• For a full, detailed list, view our report
Market Challenge
• Increase in Aging Population
• For a full, detailed list, view our report
Market Trend
• Increase in Global Healthcare Spending
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Coagulation Testing Application
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08. Market Segmentation by Technology
08.1 Electrochemical
08.2 Optical
08.3 Molecular PCR-based
09. Market Segmentation by Types Coagulation Tests
10. Market Segmentation by End-users
10.1 Global Point-of-Care Coagulation Testing Market
10.1.1 Market Size and Forecast
10.2 Global Home Diagnostics Market
10.2.1 Market Size and Forecast
11. Geographical Segmentation
11.1 Coagulation Testing Market in the Americas
11.1.1 Market Size and Forecast
11.2 Coagulation Testing Market in the EMEA Region
11.2.1 Market Size and Forecast
11.3 Coagulation Testing Market in the APAC Region
11.3.1 Market Size and Forecast
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and their Impact
19. Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2013
19.3 Other Prominent Vendors
19.4 Abbott Laboratories
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Business Segmentation by Revenue
19.4.4 Business Segmentation by Revenue 2011 and 2012
19.4.5 Geographical Segmentation by Revenue
19.4.6 Business Strategy
19.4.7 Key Information
19.4.8 SWOT Analysis
19.5 Danaher
19.5.1 Key Facts
19.5.2 Business Overview
19.5.3 Business Segmentation
19.5.4 Revenue by Business Segmentation
19.5.5 Revenue Comparison 2012 and 2013
19.5.6 Segmentation by Geography
19.5.7 Business Strategy
19.5.8 Key Information
19.5.9 SWOT Analysis
19.6 Roche Diagnostics
19.6.1 Key Facts
19.6.2 Business Overview
19.6.3 Business Segmentation by Revenue 2013
19.6.4 Geographical Segmentation by Revenue 2013
19.6.5 Business Strategy
19.6.6 Recent Developments
19.6.7 SWOT Analysis
19.7 Sysmex
19.7.1 Key Facts
19.7.2 Business Overview
19.7.3 Product Segmentation by Revenue 2014
19.7.4 Product Segmentation by Revenue 2013 and 2014
19.7.5 Geographical Segmentation by Revenue 2014
19.7.6 Business Strategy
19.7.7 Recent Developments
19.7.8 SWOT Analysis
20. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Coagulation Testing Market 2013-2018 (US$ million)
Exhibit 3: Global Coagulation Testing Market Segmentation by Technology
Exhibit 4: Global Coagulation Testing Market Segmentation by Test
Exhibit 5: Global Coagulation Testing Market Segmentation by End-users
Exhibit 6: Global Coagulation Testing Market Segmentation by End-users 2013
Exhibit 7: Global Point-of-Care Coagulation Testing Market 2013-2018 (US$ million)
Exhibit 8: Global Home Diagnostics Market 2013-2018 (US$ million)
Exhibit 9: Global Coagulation Testing Market Segmentation by End-user 2013-2018
Exhibit 10: Global Coagulation Testing Market Segmentation by End-user 2013-2018 (US$ million)
Exhibit 11: Global Coagulation Testing Market by Geographical Segmentation 2013
Exhibit 12: Coagulation Testing Market in the Americas 2013-2018 (US$ million)
Exhibit 13: Coagulation Testing Market in the EMEA Region 2013-2018 (US$ million)
Exhibit 14: Coagulation Testing Market in the APAC Region 2013-2018 (US$ million)
Exhibit 15: Global Coagulation Testing Market Segmentation by Geography 2013-2018
Exhibit 16: Global Coagulation Testing Market Segmentation by Geography 2013-2018 (US$ million)
Exhibit 17: Abbott Laboratories: Business Segmentation by Revenue 2012
Exhibit 18: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 (US$ million)
Exhibit 19: Abbott Laboratories: Geographical Segmentation by Revenue 2012
Exhibit 20: Danaher: Business Segmentation
Exhibit 21: Danaher: Business Segmentation 2013
Exhibit 22: Danaher: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 23: Danaher: Revenue by Geographical Segmentation 2013
Exhibit 24: Roche Diagnostics: Business Segmentation by Revenue 2013
Exhibit 25: Roche Diagnostics: Geographical Segmentation by Revenue 2013
Exhibit 26: Sysmex: Product Segmentation by Revenue 2014
Exhibit 27: Sysmex: Product Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 28: Sysmex: Geographical Segmentation by Revenue 2014
